Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature

References

• Bushman W. Etiology, epidemiology, and natural history. Urol Clin North Am. 2009;36(4):403–415. doi:10.1016/j.ucl.2009.07.003
   PubMed Web of Science ®Google Scholar
• Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II—surgical evaluation and treatment. J Urol. 2021;206(4):818–826. doi:10.1097/ju.0000000000002184
   PubMed Web of Science ®Google Scholar
• Bortnick E, Brown C, Simma-Chiang V, Kaplan SA. Modern best practice in the management of benign prostatic hyperplasia in the elderly. Ther Adv Urol. 2020;12. doi:10.1177/1756287220929486
   Web of Science ®Google Scholar
• Lotterstätter M, Seklehner S, Wimpissinger F, et al. Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study. World J Urol. 2022;40(12):3015–3020. doi:10.1007/s00345-022-04179-w
   PubMed Web of Science ®Google Scholar
• Yang EJ, Li H, Sun XB, et al. Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk. Sci Rep. 2016;6(1). doi:10.1038/srep21494
   Google Scholar
• Mmeje CO, Nunez-Nateras R, Warner JN, Humphreys MR. Age-stratified outcomes of holmium laser enucleation of the prostate. BJU Int. 2013;35(5). doi:10.1111/bju.12063
   Google Scholar
• Tamalunas A, Westhofen T, Schott M, et al. The clinical value of holmium laser enucleation of the prostate in octogenarians. LUTS. 2020;13(2):279–285. doi:10.1111/luts.12366
   Google Scholar
• Piao S, Choo MS, Kim M, Jeon HJ, Oh SJ. Holmium laser enucleation of the prostate is safe for patients above 80 years: a prospective study. Int Neurourol J. 2016;20(2):143–150. doi:10.5213/inj.1630478.239
   PubMed Web of Science ®Google Scholar
• Gild P, Lenke L, Pompe RS, et al. Assessing the outcome of holmium laser enucleation of the prostate by age, prostate volume, and a history of blood thinning agents: report from a single-center series of >1800 consecutive cases. J Endourol. 2021;35(5):639–646. doi:10.1089/end.2020.0605
   PubMed Web of Science ®Google Scholar
• Elshal AM, Elmansy HM, Elhilali MM. Transurethral laser surgery for benign prostate hyperplasia in octogenarians: safety and outcomes. Urology. 2013;81(3):634–639. doi:10.1016/j.urology.2012.11.042
   PubMed Web of Science ®Google Scholar
• Castellani D, Pirola GM, Gasparri L, et al. Are outcomes of thulium laser enucleation of the prostate different in men aged 75 and over? A propensity score analysis. Urology. 2019;132:170–176. doi:10.1016/j.urology.2019.06.025
   PubMed Web of Science ®Google Scholar
• Hou CP, Lin YH, Juang HH, et al. Clinical outcome of transurethral enucleation of the prostate using the 120-W thulium Laser (VelaTM XL) compared to bipolar transurethral resection of the prostate (TURP) in aging male. Aging. 2020;12(2):1888–1898. doi:10.18632/aging.102720
   PubMedGoogle Scholar
• Bouhadana D, Nguyen DD, Zhang X, et al. Safety and efficacy of TURP vs. laser prostatectomy for the treatment of benign prostatic hyperplasia in multi-morbid and elderly individuals aged ≥ 75. World J Urol. 2021;39(12):4405–4412. doi:10.1007/s00345-021-03779-2
   PubMed Web of Science ®Google Scholar
• Stoddard MD, Zheng X, Mao J, Te A, Sedrakyan A, Chughtai B. Safety and efficacy of outpatient surgical procedures for the treatment of benign prostatic enlargement in New York state and California (2005–2016). J Urol. 2021;205(3):848–854. doi:10.1097/ju.0000000000001401
   PubMed Web of Science ®Google Scholar
• Rajih E, Tholomier C, Hueber PA, et al. Evaluation of surgical outcomes with photoselective greenLight XPS laser vaporization of the prostate in high medical risk men with benign prostatic enlargement: a multicenter study. J Endourol. 2017;31(7):686–693. doi:10.1089/end.2016.0782
   PubMed Web of Science ®Google Scholar
• Nguyen DD, Deyirmendjian C, Law K, et al. GreenLight photovaporization of the prostate in high-medical-risk patients: an analysis of the Global GreenLight Group (GGG) database. World J Urol. 2022;40(7):1755–1762. doi:10.1007/s00345-022-03986-5
   PubMed Web of Science ®Google Scholar
• Majumdar R, Mirheydar HS, Palazzi KL, Lakin CM, Albo ME, Parsons JK. Prostate laser vaporization is safe and effective in elderly men. Urol Ann. 2015;7(1):36. doi:10.4103/0974-7796.148595
   PubMedGoogle Scholar
• Castellani D, Di Rosa M, Gasparri L, Pucci M, Dellabella M. Thulium laser vapoenucleation of the prostate (ThuVEP) in men at high cardiovascular risk and on antithrombotic therapy: a single-center experience. J Clin Med. 2020;9(4):917. doi:10.3390/jcm9040917
   PubMed Web of Science ®Google Scholar
• Chang CH, Lin TP, Chang YH, Huang WJ, Lin AT, Chen KK. Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study. BMC Urol. 2015;15(1). doi:10.1186/s12894-015-0032-7
   Google Scholar
• Becker B, Orywal AK, Gross AJ, Netsch C. Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 mL: long-term durability of the procedure. Lasers Med Sci. 2019;34(8):1637–1643. doi:10.1007/s10103-019-02760-1
   PubMed Web of Science ®Google Scholar
• Taktak S, Jones P, Haq A, Rai BP, Somani BK. Aquablation: a novel and minimally invasive surgery for benign prostate enlargement. Ther Adv Urol. 2018;10(6):183–188. doi:10.1177/1756287218760518
   PubMed Web of Science ®Google Scholar
• Gilling P, Reuther R, Kahokehr A, Fraundorfer M. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 2016;117(6):923–929. doi:10.1111/bju.13358
   PubMed Web of Science ®Google Scholar
• Raizenne BL, Bouhadana D, Zorn KC, et al. Functional and surgical outcomes of Aquablation in elderly men. World J Urol. 2022;40(10):2515–2520. doi:10.1007/s00345-022-04137-6
   PubMed Web of Science ®Google Scholar
• Cantrill CH, Zorn KC, Elterman DS, Gonzalez RR. The Rezūm system - A minimally invasive water vapor thermal therapy for obstructive benign prostatic hyperplasia. Can J Urol. 2019;26(3):9787–9793.
   PubMed Web of Science ®Google Scholar
• McVary KT, Holland B, Beahrs JR. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2019;23:303–308. doi:10.1038/s41391-019-0187-5
   PubMed Web of Science ®Google Scholar
• Bassily D, Wong V, Phillips JL, et al. Rezūm for retention—retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia. Prostate. 2021;81(14):1049–1054. doi:10.1002/pros.24201
   PubMed Web of Science ®Google Scholar
• Darson MF, Alexander EE, Schiffman ZJ, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol. 2017;9:159–168. doi:10.2147/rru.s143679
   PubMed Web of Science ®Google Scholar
• Tadrist A, Baboudjian M, Bah MB, et al. Water vapor thermal therapy for indwelling urinary catheter removal in frail patients. Int Urol Nephrol. 2022;55:249–253. doi:10.1007/s11255-022-03408-w
   PubMed Web of Science ®Google Scholar
• Eredics K, Wehrberger C, Henning A, et al. Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis. 2021;25(2):302–305. doi:10.1038/s41391-021-00462-w
   PubMed Web of Science ®Google Scholar
• Garcia C, Chin P, Rashid P, Woo HH. Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prost Inter. 2015;3(1):1–5. doi:10.1016/j.prnil.2015.02.002
   PubMedGoogle Scholar
• Lehner K, Popat S, Utech K, Taylor J, Brooks M and Jones J. Outcomes of prostatic urethral lift in a medically complex population at a veterans affairs hospital. BJUI Compass, (2022). 3(3), 214–219. 10.1002/bco2.126
   PubMedGoogle Scholar
• Papatsoris A, Zachou, Kachrilas, Masood, Buchholz and Junaid. New developments in the use of prostatic stents. OAJU, (2011). 63 10.2147/OAJU.S11752
   Google Scholar
• Wang MQ, Wang Y, Yan JY, et al. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study. World J Urol. 2016;34(9):1275–1283. doi:10.1007/s00345-016-1771-0
   PubMed Web of Science ®Google Scholar
• Rampoldi A, Barbosa F, Secco S, et al. Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates. Cardiovasc Intervent Radiol. 2017;40(4):530–536. doi:10.1007/s00270-017-1582-8
   PubMed Web of Science ®Google Scholar
• Gabr AH, Gabr MF, Elmohamady BN, Ahmed A. Prostatic artery embolization: a promising technique in the treatment of high-risk patients with benign prostatic hyperplasia. Urol Int. 2016;97(3):320–324. doi:10.1159/000447360
   PubMed Web of Science ®Google Scholar
• Bhatia S, Sinha VK, Kava BR, et al. Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol. 2018;29(1):78–84.e1. doi:10.1016/j.jvir.2017.08.022
   PubMed Web of Science ®Google Scholar
• Pariser JJ, Pearce SM, Patel SG, Bales GT. National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes. Urology. 2015;86(4):721–726. doi:10.1016/j.urology.2015.06.04
   PubMed Web of Science ®Google Scholar
• Helgason ÁR, Adolfsson J, Dickman P, et al. Sexual desire, erection, orgasm and ejaculatory functions and their importance to elderly Swedish men: a population-based study. Age Ageing. 1996;25(4):285–291. doi:10.1093/ageing/25.4.285
   PubMed Web of Science ®Google Scholar